MECWINS Welcomes High School Students for an Immersive Research Experience
This week, we had the [...]
Mecwins at the 2nd CTB Workshop on Bioinstrumentation and Nanomedicine
Last Thursday we had the pleasure of attending [...]
Mecwins at CSIC spin-off launch: Driving Innovation
Mecwins is pleased to announce its participation in [...]
Advancing Drug-Induced Liver Injury Detection
Drug-induced liver injury (DILI) remains a major challenge [...]
Mecwins Advances the Determination of pTau217 and pTau181 Biomarker Levels for Alzheimer’s Disease
© Juan Gärtner/stock.adobe.com At Mecwins, we are pushing [...]
Revolutionary AVAC technology for ultra-sensitive and high-throughput biomarker detection unveiled!
At Mecwins, we are excited to share the publication [...]
Mecwins Leads Revolution in Cancer Drug Monitoring
We're excited to announce that Mecwins is playing [...]
Mecwins and Destina Genómica receive CDTI support for an innovative breast cancer early detection project
We are thrilled to share some exciting news: Mecwins, [...]
Exploring the Future of Instrumentation at JCTI – Universidad Autónoma de Madrid
Last Thursday, our CEO Óscar Ahumada and our [...]
